Provident Trust Company’s Johnson & Johnson JNJ Stock Holding History

Provident Trust Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,400	Closed	-$398K	–	25
2025 Q1	$398K	Hold	2,400	–	–	0.01%	26
2024 Q4	$347K	Sell	2,400 -109	-4%	-$16.9K	0.01%	25
2024 Q3	$407K	Hold	2,509	–	–	0.01%	27
2024 Q2	$367K	Hold	2,509	–	–	0.01%	27
2024 Q1	$397K	Hold	2,509	–	–	0.01%	27
2023 Q4	$393K	Sell	2,509 -132	-5%	-$20.2K	0.01%	27
2023 Q3	$411K	Hold	2,641	–	–	0.01%	26
2023 Q2	$437K	Hold	2,641	–	–	0.01%	26
2023 Q1	$409K	Hold	2,641	–	–	0.01%	26
2022 Q4	$467K	Hold	2,641	–	–	0.01%	25
2022 Q3	$431K	Sell	2,641 -75	-3%	-$12.7K	0.01%	21
2022 Q2	$482K	Hold	2,716	–	–	0.01%	20
2022 Q1	$481K	Hold	2,716	–	–	0.01%	22
2021 Q4	$465K	Hold	2,716	–	–	0.01%	25
2021 Q3	$439K	Sell	2,716 -2,030	-43%	-$346K	0.01%	25
2021 Q2	$782K	Hold	4,746	–	–	0.02%	21
2021 Q1	$780K	Hold	4,746	–	–	0.02%	22
2020 Q4	$747K	Sell	4,746 -35	-0.7%	-$5.17K	0.02%	22
2020 Q3	$712K	Hold	4,781	–	–	0.02%	22
2020 Q2	$672K	Hold	4,781	–	–	0.02%	23
2020 Q1	$627K	Hold	4,781	–	–	0.02%	20
2019 Q4	$697K	Sell	4,781 -77	-2%	-$10.4K	0.02%	24
2019 Q3	$629K	Hold	4,858	–	–	0.02%	25
2019 Q2	$677K	Hold	4,858	–	–	0.02%	22
2019 Q1	$679K	Hold	4,858	–	–	0.03%	21
2018 Q4	$627K	Sell	4,858 -195	-4%	-$27.2K	0.03%	20
2018 Q3	$698K	Sell	5,053 -37	-0.7%	-$4.92K	0.02%	19
2018 Q2	$618K	Hold	5,090	–	–	0.02%	19
2018 Q1	$652K	Hold	5,090	–	–	0.03%	19
2017 Q4	$711K	Hold	5,090	–	–	0.03%	20
2017 Q3	$662K	Hold	5,090	–	–	0.03%	20
2017 Q2	$673K	Hold	5,090	–	–	0.03%	20
2017 Q1	$634K	Hold	5,090	–	–	0.03%	20
2016 Q4	$586K	Hold	5,090	–	–	0.03%	20
2016 Q3	$601K	Hold	5,090	–	–	0.03%	20
2016 Q2	$617K	Hold	5,090	–	–	0.03%	21
2016 Q1	$551K	Hold	5,090	–	–	0.03%	21
2015 Q4	$523K	Sell	5,090 -480	-9%	-$48.3K	0.03%	21
2015 Q3	$520K	Sell	5,570 -247	-4%	-$23.9K	0.03%	20
2015 Q2	$567K	Hold	5,817	–	–	0.03%	19
2015 Q1	$585K	Sell	5,817 -90	-2%	-$9.15K	0.03%	18
2014 Q4	$618K	Sell	5,907 -340	-5%	-$35.8K	0.04%	18
2014 Q3	$666K	Hold	6,247	–	–	0.04%	19
2014 Q2	$654K	Buy	6,247 +4,000	+178%	+$404K	0.04%	19
2014 Q1	$221K	Hold	2,247	–	–	0.01%	20
2013 Q4	$206K	Buy	+2,247	New	+$207K	0.01%	21

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Provident Trust Company's JNJ Position: Q2 2025 in Review

Provident Trust Company sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 2,400 shares — an estimated $398K sold.

Provident Trust Company first reported a position in JNJ in Q4 2013 and held it in 46 quarters. The position peaked at $782K in Q2 2021. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

Provident Trust Company reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
Provident Trust Company sold 2,400 Johnson & Johnson shares in Q2 2025, an estimated $398K.
Provident Trust Company first reported a position in Johnson & Johnson in Q4 2013 and held it in 46 quarters.
Provident Trust Company's Johnson & Johnson position peaked at $782K in Q2 2021.
4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Provident Trust Company's 13F filing for Q2 2025, filed 4 Aug 2025.